Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Higher PSA levels are linked to more hirsutism in women with PCOS.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

CT scans can find serious prostate cancer even when PSA levels are low.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

New treatments for male hypogonadism are effective and should be personalized.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.

Combining advanced sensors with portable devices could enhance on-site food safety monitoring.

Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.